Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
(adsbygoogle = window.adsbygoogle || []).push({}); Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized More...
Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe Covid-19 patients. Foralumab is an anti-CD3 human monoclonal antibody More...
Pfizer begins phase 1 study of Covid drug candidate PF-07321332
Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that causes Covid-19. The US pharma giant said that it has completed More...
Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses
AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442, the company’s Covid-19 antibody candidate, for a sum of $205 million. In this connection, AstraZeneca has More...
Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of Covid-19. The company’s investigational new drug (IND) application More...
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from the Drugs Controller General of India (DCGI). The Indian More...
Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India
US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...
Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India
US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...
UAE approves Russia-made Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection More...
UAE approves Russia-made Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection More...